Investor Relations.

Corporate
Investor Deck

View The Deck >

News

ImmVirX In the News | Company Announcements

ImmVirX enters the clinic with next generation oncolytic virus

Company Announcements

April 11, 2023

Dr Malcolm McColl

ImmVirX raising $25m led by renowned healthcare VC OneVentures

Company Announcements

June 5, 2023

ImmVirX raising $25m led by renowned healthcare VC OneVentures

Company Announcements

May 19, 2021

by

ImmVirX receives $2.81M R&D tax refund for FY22

Company Announcements

November 28, 2022

ImmVirX receives $2.81M R&D tax refund for FY22

Company Announcements

May 19, 2021

by

AFR Higher Education Award Research Commercialisation

AFR Higher Education Award Research Commercialisation

Nov 13, 2020

by

ImmVirX reports on operations for FY22

Company Announcements

September 26, 2022

ImmVirX reports on operations for FY22

Company Announcements

May 19, 2021

by

ImmVirX receives $858,183 R&D tax refund

Company Announcements

ImmVirX receives $858,183 R&D tax refund

Company Announcements

May 19, 2021

by

ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024

Company Announcements

December 6, 2021

ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024

Company Announcements

May 19, 2021

by

ImmVirX closes upsized $25m Series A financing

Company Announcements

November 8, 2021

ImmVirX closes upsized $25m Series A financing

Company Announcements

May 19, 2021

by

Bioshares Interview: Malcolm McColl, CEO ImmVirX

July 13, 2021

Bioshares Interview: Malcolm McColl, CEO ImmVirX

Nov 13, 2020

by

ImmVirX Announces $22 Million Series A Financing

Company Announcements

May 14, 2021

ImmVirX Announces $22 Million Series A Financing

Company Announcements

May 19, 2021

by

Viralytics band gets back together for ImmVirX cancer start-up

May 13, 2021

Viralytics band gets back together for ImmVirX cancer start-up

Nov 13, 2020

by

$500m Cancer team reassembled

March 9, 2021

$500m Cancer team reassembled

Nov 13, 2020

by

New biotech venture going viral in battle against cancer

January 22, 2020

New biotech venture going viral in battle against cancer

Nov 13, 2020

by

ImmVirX featured in a recent ABC coverage of the Australian Biotech sector

February 12, 2020

ImmVirX featured in a recent ABC coverage of the Australian Biotech sector

Nov 13, 2020

by

The Newcastle Herald features Immvirx on its work to develop cutting-edge cancer therapies

January 22, 2020

The Newcastle Herald features Immvirx on its work to develop cutting-edge cancer therapies

Nov 13, 2020

by

Company Announcements

ImmVirX raising $25m led by renowned healthcare VC OneVentures

Company Announcements

June 5, 2023

ImmVirX raising $25m led by renowned healthcare VC OneVentures

Company Announcements

May 19, 2021

by

ImmVirX enters the clinic with next generation oncolytic virus

Company Announcements

April 11, 2023

ImmVirX enters the clinic with next generation oncolytic virus

Company Announcements

May 19, 2021

by

Dr Malcolm McColl

ImmVirX receives $2.81M R&D tax refund for FY22

Company Announcements

November 28, 2022

ImmVirX receives $2.81M R&D tax refund for FY22

Company Announcements

May 19, 2021

by

ImmVirX reports on operations for FY22

Company Announcements

September 26, 2022

ImmVirX reports on operations for FY22

Company Announcements

May 19, 2021

by

ImmVirX receives $858,183 R&D tax refund

Company Announcements

ImmVirX receives $858,183 R&D tax refund

Company Announcements

May 19, 2021

by

ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024

Company Announcements

December 6, 2021

ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024

Company Announcements

May 19, 2021

by

ImmVirX closes upsized $25m Series A financing

Company Announcements

November 8, 2021

ImmVirX closes upsized $25m Series A financing

Company Announcements

May 19, 2021

by

Resignation of Chairman – Peter Turvey

Company Announcements

August 4, 2021

Resignation of Chairman – Peter Turvey

Company Announcements

May 19, 2021

by

ImmVirX Announces $22 Million Series A Financing

Company Announcements

May 14, 2021

ImmVirX Announces $22 Million Series A Financing

Company Announcements

May 19, 2021

by

Join Our Mailing List

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect